Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Wilding

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group StudyR Dreicer, J Manola, B J Roth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Evidence of an absorption phase after short intravenous suramin infusionsP R Hutson, K Tutsch, D Spriggs, et al.
Endocrine|November 3, 1998
Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaquesH J Pan, G Wilding, H Uno, et al.
Cancer|October 15, 1993
Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the Eastern Cooperative Oncology GroupB J Roth, B Y Yeap, G Wilding, et al.
International Journal of Oncology|November 20, 2001
Identification of the prostate cancer micro-foci with chromosome 8p deletion at the tumor interface area by histopathological-FISH parallel examinationS Q Wu, G R Hafez, J Zhang, et al.
Cancer Research|February 15, 1991
Phase I clinical trial of fazarabine as a twenty-four-hour continuous infusionH Bailey, K D Tutsch, R Z Arzoomanian, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
A phase I study of 5-fluorouracil, leucovorin and levamisoleJ F Cleary, R Arzoomanian, D Alberti, et al.
Investigational New Drugs|November 1, 1992
Phase I evaluation of 773U82-HCl in a two-hour infusion repeated daily for three daysH Bailey, P Kohler, R Tuttle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
Retinal toxicity after high-dose cisplatin therapyG Wilding, R Caruso, T S Lawrence, et al.
Investigational New Drugs|January 1, 1994
A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinomaJ Berlin, A C King, K Tutsch, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: an Eastern Cooperative Oncology Group StudyR Dreicer, J Manola, B J Roth, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Evidence of an absorption phase after short intravenous suramin infusionsP R Hutson, K Tutsch, D Spriggs, et al.
Endocrine|November 3, 1998
Evaluation of RU58841 as an anti-androgen in prostate PC3 cells and a topical anti-alopecia agent in the bald scalp of stumptailed macaquesH J Pan, G Wilding, H Uno, et al.
Cancer|October 15, 1993
Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the Eastern Cooperative Oncology GroupB J Roth, B Y Yeap, G Wilding, et al.
International Journal of Oncology|November 20, 2001
Identification of the prostate cancer micro-foci with chromosome 8p deletion at the tumor interface area by histopathological-FISH parallel examinationS Q Wu, G R Hafez, J Zhang, et al.
Cancer Research|February 15, 1991
Phase I clinical trial of fazarabine as a twenty-four-hour continuous infusionH Bailey, K D Tutsch, R Z Arzoomanian, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
A phase I study of 5-fluorouracil, leucovorin and levamisoleJ F Cleary, R Arzoomanian, D Alberti, et al.
Investigational New Drugs|November 1, 1992
Phase I evaluation of 773U82-HCl in a two-hour infusion repeated daily for three daysH Bailey, P Kohler, R Tuttle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1985
Retinal toxicity after high-dose cisplatin therapyG Wilding, R Caruso, T S Lawrence, et al.
Investigational New Drugs|January 1, 1994
A phase II study of vinblastine in combination with acrivastine in patients with advanced renal cell carcinomaJ Berlin, A C King, K Tutsch, et al.
Pageof 11